◀ Back to GATA1

GATA1 — GATA5

Text-mined interactions from Literome

Yang et al., Leukemia 2006 (Leukemia, Myeloid, Acute) : The GATA site dependent hemogen promoter is transcriptionally regulated by GATA1 in hematopoietic and leukemia cells
Geron et al., Cancer Cell 2008 (Polycythemia Vera) : TG101348 treatment decreased GATA-1 expression, which is associated with erythroid skewing of JAK2V617F+ progenitor differentiation, and inhibited STAT5 as well as GATA S310 phosphorylation
Gong et al., Mol Cell Biol 1991 : Point mutations demonstrate that GATA-1 binding to this site is necessary for interaction with an erythroid-specific enhancer but that in the absence of an enhancer, GATA-1 does not increase transcription
Harigae et al., Genes Cells 1998 : These results suggest that the expression of GATA factor dependent genes is regulated by GATA-2 during mast cell development and that GATA-1 is required for the specification of differentiated mast cell phenotypes